Dose-response and pharmacokinetic characterization in cellular and pre-clinical models
Potential adjustments include confirming you are at an adequate dose (some people need to reach 8mg or 12mg before seeing meaningful movement), auditing protein intake and meal timing, evaluating hydration compliance, or discussing the protocol with a healthcare provider
GMP, GLP and Quality Assurance in the laboratory According to PIC/S, adherence to GLP in nonclinical studies is the only way to ensure product safety
This may also increase long-term health risks
This study suggests that the patients with low GLP-1 signaling score may benefit from immune checkpoint inhibitor treatment in some cancers
The escalation to 8-12 mg occurs over roughly the same 16-20 week period as semaglutide, though the magnitude of dose increases is proportionally larger